SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ID Biomedical - Elephant Hunting?? (IDBEF) -- Ignore unavailable to you. Want to Upgrade?

To: Kaiser Soza who wrote (4)1/24/1999 10:59:00 PM
From: Steve Lokness  Read Replies (1) | Respond to of 27
 
Kaiser;
Interesting comments. Have you been in contact with the new management?

How well do you understand their CPT technology? Is my understanding that they would just sell off the rights to this test rather than do any manufactuing themselves - correct? Any idea what kind of money might be involved?

Would sure appreciate hearing more of your understanding of the CPT testing procedure.

Good Investing;
Steve



To: Kaiser Soza who wrote (4)1/28/1999 5:33:00 PM
From: Ignite44  Read Replies (1) | Respond to of 27
 
Hi Kaiser,

Regarding the deal with Pasteur Merieux to develop the TB vaccine, my understanding is that development has been put on hold because of profitability issues. If true, that would explain why the market is ignoring the deal. Do you know anything about this?

Thanks


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News